Vasoactive Intestinal Peptide and Nitric Oxide: Divergent Roles in Relation to Tissue Injury
- 17 December 2006
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 805 (1) , 379-387
- https://doi.org/10.1111/j.1749-6632.1996.tb17498.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Vasoactive intestinal polypeptide biologic role in health and diseasePublished by Elsevier ,2005
- Vasoactive intestinal peptide inhibits fMLP-induced respiratory burst in human lymphocytesLife Sciences, 1994
- VASOACTIVE INTESTINAL PEPTIDE ENHANCES LUNG PRESERVATIONTransplantation, 1993
- N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin.The Journal of Experimental Medicine, 1992
- Inhibition of Interleukin-1- -Induced Nitric Oxide Synthase in Vascular Smooth Muscle and Full Reversal of Interleukin-1- -Induced Hypotension by N -Amino-L-arginineJNCI Journal of the National Cancer Institute, 1992
- Nitric oxide: a pathogenetic factor in autoimmunityImmunology Today, 1992
- Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the ratPeptides, 1991
- Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptideNature, 1988
- Effect of Vasoactive Intestinal Peptide on Myocardial Contractility and Coronary Blood Flow in the DogJournal of Cardiovascular Pharmacology, 1988
- Vasoactive Intestinal Peptide Protects Against HCl‐Induced Pulmonary Edema in RatsAnnals of the New York Academy of Sciences, 1988